Showing results (431-440 of 438) with videos related to
Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 438 results.
Journal of the National Cancer Institute|September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinomaAmmar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.Cancer Letters|October 31, 2020
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017Ding Ding, Ammar A Javed, Dea Cunningham, et al.Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.British Journal of Cancer|May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.Annals of Surgery|March 5, 2019
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome ComparisonsPatricia Sánchez-Velázquez, Xavier Muller, Giuseppe Malleo, et al.JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter studyE Rangelova, T F Stoop, T M E van Ramshorst, et al.Pageof 44